These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 17297027

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG, Looareesuwan S, Chulay JD.
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.
    Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DB.
    Am J Trop Med Hyg; 1999 Apr; 60(4):533-41. PubMed ID: 10348225
    [Abstract] [Full Text] [Related]

  • 6. [Value of malarone in therapy of malaria tropica].
    Ziegler T, Schau A, Winkler C.
    Med Klin (Munich); 2002 Aug 15; 97(8):455-8. PubMed ID: 12229244
    [Abstract] [Full Text] [Related]

  • 7. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
    Sutherland CJ, Laundy M, Price N, Burke M, Fivelman QL, Pasvol G, Klein JL, Chiodini PL.
    Malar J; 2008 Nov 20; 7():240. PubMed ID: 19021900
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Atovaquone-proguanil treatment failure in Plasmodium falciparum].
    Contentin L, Grammatico-Guillon L, Desoubeaux G, Baron S, Thanh HD.
    Presse Med; 2011 Nov 20; 40(11):1081-3. PubMed ID: 21570798
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
    Legrand E, Demar M, Volney B, Ekala MT, Quinternet M, Bouchier C, Fandeur T, Rogier C, Carme B, Puijalon OM, Esterre P.
    Antimicrob Agents Chemother; 2007 Jun 20; 51(6):2280-1. PubMed ID: 17438062
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group.
    Kimura M, Koga M, Kikuchi T, Miura T, Maruyama H.
    Parasitol Int; 2012 Sep 20; 61(3):466-9. PubMed ID: 22484597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.